12.08EUR0.00%Mkt Cap: 334.90M $P/E: 21.571d ago
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. …
Indicators:|
Key Statistics
Company
Market Cap334.90M $
Enterprise Value407.82M $
Revenue (TTM)2.31B $
Gross Profit216.49M $
Net Income (TTM)16.70M $
Revenue/Share93.00 USD
Last Price12.08 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees993
CountryDE
SectorHealthcare
IndustryMedical Distribution
ISINDE000A1MMCC8
Valuation
P/E (Trailing)21.57
P/E (Forward)7.08
PEG—
EV/EBITDA5.13
EV/Revenue0.18
P/S0.15
P/B0.57
EPS (TTM)0.56
EPS (Forward)1.71
52W Range
11.648% of range17.44
52W High17.44 EUR
52W Low11.64 EUR
Profitability
Gross Margin9.58%
Oper. Margin1.89%
EBITDA Margin3.45%
Profit Margin0.74%
ROE2.99%
ROA1.70%
Growth
Revenue Growth8.90%
Earnings Growth-20.00%
Cash Flow & Leverage
Operating CF56.82M $
CapEx (TTM)9.01M $
FCF Margin3.50%
FCF Yield24.12%
Net Debt85.94M $
Net Debt/EBITDA1.08
Balance Sheet
Debt/Equity0.37
Current Ratio1.93
Quick Ratio1.39
Book Value/Sh21.20 EUR
Cash/Share3.818 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:4
Split DateJul 19, 2012
Analyst Consensus
Rating—
Target (Mean)23.00 EUR
Upside (mean)+90.4%
Target Range18.00 EUR – 26.00 EUR
€18.00+90.4% to mean€26.00
# Analysts4
Ownership
Shares Out.25.51M
Float8.33M
Insiders19.70%
Institutions51.46%
Technical
SMA 5013.05 (-7.4%)
SMA 20013.99 (-13.7%)
Beta1.31
S&P 52W Chg20.05%
Avg Vol (30d)34.09K
Avg Vol (10d)27.61K
Technical Indicators
RSI (14)38.4
MACD-0.2564
MACD Signal-0.2412
MACD Hist.-0.0152
BB Upper13.07 EUR
BB Middle12.42 EUR
BB Lower11.76 EUR
BB Width10.54%
ATR (14)0.4231 EUR
Vol Ratio (20d)0.92x